We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
(-11%)
Cap. Flow
-$3.05B
Cap. Flow
% of AUM
-17.25%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$113M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$106M |
| 3 |
Merck
MRK
|
+$95.9M |
| 4 |
Baidu
BIDU
|
+$85.8M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$229M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 15.39% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 10.48% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
W.W. Grainger
GWW
$60.2B
| $278K | ﹤0.01% |
+900
| New | +$269K |
|
1202
Unitil
UTL
$980M
| $276K | ﹤0.01% |
+5,411
| New | +$261K |
|
|
SECO
1203
DELISTED
Secoo Holding Limited ADR
SECO
| $276K | ﹤0.01% |
+3,419
| New | +$343K |
|
1204
Newmont
NEM
$119B
| $275K | ﹤0.01% |
+7,300
| New | +$287K |
|
|
HNP
1205
DELISTED
Huaneng Power Intl, Inc.
HNP
| $275K | ﹤0.01% |
+10,486
| New | +$284K |
|
1206
Goldgroup Mining Inc.
GORO
$191M
| $267K | ﹤0.01% |
+40,582
| New | +$228K |
|
|
RCM
1207
DELISTED
R1 RCM Inc. Common Stock
RCM
| $267K | ﹤0.01% |
+30,757
| New | +$249K |
|
|
UBNK
1208
DELISTED
United Financial Bancorp, Inc.
UBNK
| $266K | ﹤0.01% |
15,180
-29,297
| -66% | -$503K |
|
1209
China Yuchai International
CYD
$1.78B
| $265K | ﹤0.01% |
+12,210
| New | +$264K |
|
|
NRE
1210
DELISTED
NorthStar Realty Europe Corp.
NRE
| $264K | ﹤0.01% |
18,236
-15,954
| -47% | -$224K |
|
1211
Willdan Group
WLDN
$1.3B
| $262K | ﹤0.01% |
8,446
-59,437
| -88% | -$1.72M |
|
|
HEP
1212
DELISTED
Holly Energy Partners, L.P.
HEP
| $262K | ﹤0.01% |
+9,270
| New | +$270K |
|
|
PETX
1213
DELISTED
Aratana Therapeutics, Inc.
PETX
| $262K | ﹤0.01% |
61,677
-96,853
| -61% | -$488K |
|
1214
Lumen
LUMN
$6.44B
| $261K | ﹤0.01% |
+14,000
| New | +$254K |
|
1215
TE Connectivity
TEL
$62.6B
| $261K | ﹤0.01% |
+2,900
| New | +$278K |
|
|
CQH
1216
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $259K | ﹤0.01% |
8,237
-50,392
| -86% | -$1.46M |
|
1217
Cardlytics
CDLX
$21.5M
| $255K | ﹤0.01% |
1,170
-4,422
| -79% | -$818K |
|
1218
SmartFinancial
SMBK
$888M
| $255K | ﹤0.01% |
+9,912
| New | +$243K |
|
|
AOI
1219
DELISTED
Alliance One International
AOI
| $255K | ﹤0.01% |
+16,087
| New | +$335K |
|
1220
Baker Hughes
BKR
$61.1B
| $254K | ﹤0.01% |
+7,700
| New | +$261K |
|
1221
Fidelity National Information Services
FIS
$22.1B
| $254K | ﹤0.01% |
2,400
-18,472
| -89% | -$1.88M |
|
1222
Sonic Automotive
SAH
$2.61B
| $254K | ﹤0.01% |
12,337
+404
| +3% | +$8.43K |
|
1223
Westlake Chemical Partners
WLKP
$763M
| $251K | ﹤0.01% |
10,235
-73,139
| -88% | -$1.7M |
|
1224
Southwest Airlines
LUV
$23B
| $249K | ﹤0.01% |
+4,888
| New | +$257K |
|
1225
Freshpet
FRPT
$3.22B
| $246K | ﹤0.01% |
+8,956
| New | +$191K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.
- Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
- Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
- Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
- Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
- Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
- Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
- Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.
Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.